AAAAAA

   
Results: 1-11 |
Results: 11
COST-EFFECTIVENESS OF HELICOBACTER-PYLORI ERADICATION REGIMENS - EFFICACY VS EFFECTIVENESS
Authors: VAKIL N FENNERTY B
Citation: N. Vakil et B. Fennerty, COST-EFFECTIVENESS OF HELICOBACTER-PYLORI ERADICATION REGIMENS - EFFICACY VS EFFECTIVENESS, Gut, 41, 1997, pp. 89-89
10 VS 14 DAY TRIPLE THERAPY WITH LANSOPRAZOLE (PREVACID(R)), AMOXICILLIN, AND CLARITHROMYCIN IN THE ERADICATION OF HELICOBACTER-PYLORI (HP)
Authors: KRAUSE R PRUITT R LUKASIK N THOMAS J FENNERTY B
Citation: R. Krause et al., 10 VS 14 DAY TRIPLE THERAPY WITH LANSOPRAZOLE (PREVACID(R)), AMOXICILLIN, AND CLARITHROMYCIN IN THE ERADICATION OF HELICOBACTER-PYLORI (HP), Gut, 41, 1997, pp. 101-102
COST-EFFECTIVENESS OF TREATMENT REGIMENS FOR HELICOBACTER-PYLORI INFECTION BASED ON A COMMUNITY PRACTICE EFFECTIVENESS STUDY
Authors: VAKIL N FENNERTY B
Citation: N. Vakil et B. Fennerty, COST-EFFECTIVENESS OF TREATMENT REGIMENS FOR HELICOBACTER-PYLORI INFECTION BASED ON A COMMUNITY PRACTICE EFFECTIVENESS STUDY, Gastroenterology, 112(4), 1997, pp. 47-47
TRIPLE THERAPY WITH LANSOPRAZOLE, CLARITHROMYCIN, AND AMOXICILLIN IS HIGHLY EFFECTIVE IN THE ERADICATION OF HELICOBACTER-PYLORI INFECTION
Authors: FENNERTY B BIANCHI T ROSE P PILMER B KIDD S SIEPMAN N
Citation: B. Fennerty et al., TRIPLE THERAPY WITH LANSOPRAZOLE, CLARITHROMYCIN, AND AMOXICILLIN IS HIGHLY EFFECTIVE IN THE ERADICATION OF HELICOBACTER-PYLORI INFECTION, Gastroenterology, 112(4), 1997, pp. 116-116
EFFICACY OF HIGH-DOSE RANITIDINE (300 MG BID) IN CONTROLLING HEARTBURN IN PATIENTS POORLY RESPONSIVE TO RANITIDINE 150 MG BID
Authors: KAHRILAS PJ FENNERTY B JOELSSON B
Citation: Pj. Kahrilas et al., EFFICACY OF HIGH-DOSE RANITIDINE (300 MG BID) IN CONTROLLING HEARTBURN IN PATIENTS POORLY RESPONSIVE TO RANITIDINE 150 MG BID, Gastroenterology, 112(4), 1997, pp. 164-164
LACK OF SPONTANEOUS REGRESSION OF TUBULAR ADENOMAS IN 2 YEARS OF FOLLOW-UP
Authors: BERSENTES K FENNERTY B SAMPLINER RE GAREWAL HS
Citation: K. Bersentes et al., LACK OF SPONTANEOUS REGRESSION OF TUBULAR ADENOMAS IN 2 YEARS OF FOLLOW-UP, The American journal of gastroenterology, 92(7), 1997, pp. 1117-1120
REVERSAL OF BARRETTS-ESOPHAGUS WITH ACID SUPPRESSION AND MULTIPOLAR ELECTROCOAGULATION - PRELIMINARY-RESULTS
Authors: SAMPLINER RE FENNERTY B GAREWAL HS
Citation: Re. Sampliner et al., REVERSAL OF BARRETTS-ESOPHAGUS WITH ACID SUPPRESSION AND MULTIPOLAR ELECTROCOAGULATION - PRELIMINARY-RESULTS, Gastrointestinal endoscopy, 44(5), 1996, pp. 532-535
ECONOMIC MODELING OF MEDICAL THERAPY FOR HELICOBACTER-PYLORI RELATED PEPTIC-ULCER DISEASE
Authors: VAKIL N FENNERTY B
Citation: N. Vakil et B. Fennerty, ECONOMIC MODELING OF MEDICAL THERAPY FOR HELICOBACTER-PYLORI RELATED PEPTIC-ULCER DISEASE, Gastroenterology, 108(4), 1995, pp. 249-249
DEMONSTRATION OF A FIELD DEFECT IN GASTRIC INTESTINAL METAPLASIA BY BIOLOGICAL MARKER ANALYSIS
Authors: GAREWAL HS FENNERTY B SAMPLINER R RAMSEY L
Citation: Hs. Garewal et al., DEMONSTRATION OF A FIELD DEFECT IN GASTRIC INTESTINAL METAPLASIA BY BIOLOGICAL MARKER ANALYSIS, Cancer epidemiology, biomarkers & prevention, 3(8), 1994, pp. 683-686
ENDOSCOPIC BALLOON DILATION FOR ULCER-INDUCED GASTRIC OUTLET OBSTRUCTION
Authors: DISARIO JA FENNERTY B TIETZE CC HUTSON WR BURT RW
Citation: Ja. Disario et al., ENDOSCOPIC BALLOON DILATION FOR ULCER-INDUCED GASTRIC OUTLET OBSTRUCTION, The American journal of gastroenterology, 89(6), 1994, pp. 868-871
EXCELLENT AGREEMENT BETWEEN 3 METHODS OF MEASURING RECTAL EPITHELIAL-CELL PROLIFERATION IN PATIENTS WITH RESECTED COLON CANCER BUT LACK OF EVIDENCE OF A SUPPRESSIVE EFFECT BY PIROXICAM TREATMENT
Authors: EARNEST D HIXSON L FENNERTY B EINSPAHR J BLACKWELL G ALBERTS D
Citation: D. Earnest et al., EXCELLENT AGREEMENT BETWEEN 3 METHODS OF MEASURING RECTAL EPITHELIAL-CELL PROLIFERATION IN PATIENTS WITH RESECTED COLON CANCER BUT LACK OF EVIDENCE OF A SUPPRESSIVE EFFECT BY PIROXICAM TREATMENT, Gastroenterology, 104(4), 1993, pp. 396-396
Risultati: 1-11 |